• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7,402
3,639
3,526
2,934
2,867

COUNTRY

2,459
900
279
269
230

CATEGORIES

  • 934
  • 179
    • 43
    • 264
    • 50
  • 182
  • 295
    • 51
  • 508
  • 227
  • 242
  • 60
  • 64
  • 868
  • 1,525
  • 758
  • 20
  • 501
  • 1,433
  • 2,413
    • 85
    • 124
    • 66
    • 65
    • 37
    • 37
    • 12
    • 12
    • 11
    • 18
  • 23
  • 270
  • 32
  • 2,672
SHOW ALL…

PRICE

2,820
7,905
17,080
30,302

PUBLISHED

2,194
3,761
12,592
30,302

PRODUCT TYPE

27,327
1,090
1,035
524
163
58
23
21
20
16
6
3
1

Pharmaceuticals

(30,302 Products)

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Sleep Disorders-Pipeline Insights

This “ Sleep Disorders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for...

February 2015
FROM

Food Allergy-Pipeline Insights

This “ Food Allergy-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for...

February 2015
FROM

Fracture-Pipeline Insights

This “ Fracture-Pipeline Insights” report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline...

February 2015
FROM

Other Pain Disorders-Pipeline Insights

This “ Other Pain Disorders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Other Respiratory Disorders-Pipeline Insights

This “ Other Respiratory Disorders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Stable Angina-Pipeline Insights, 2015

This “ Stable Angina-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for...

February 2015
FROM

Arteriosclerosis-Pipeline Insights, 2015

This “ Arteriosclerosis-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Cedar Pollen Allergy-Pipeline Insights, 2015

This “ Cedar Pollen Allergy-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Colon Tumor-Pipeline Insights, 2015

This “ Colon Tumor-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all...

February 2015
FROM

Duchenne Muscular Dystrophy-Pipeline Insights

This “ Duchenne Muscular Dystrophy-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Duodenal Ulcer-Pipeline Insights

This “ Duodenal Ulcer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for...

February 2015
FROM

Hemophilia A-Pipeline Insights, 2015

This “ Hemophilia A-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for...

February 2015
FROM

Hemophillia A-Pipeline Insights

This “ Hemophillia A-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for...

February 2015
FROM

Juvenile Rheumatoid Arthritis-Pipeline Insights, 2015

This “ Juvenile Rheumatoid Arthritis-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Kaposi's Sarcoma-Pipeline Insights

This “ Kaposi's Sarcoma-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Neuroblastoma-Pipeline Insights, 2015

This “ Neuroblastoma-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for...

February 2015
FROM

Neuroendocrine Carcinoma-Pipeline Insights, 2015

This “ Neuroendocrine Carcinoma-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Retinitis Pigmentosa (Retinitis)-Pipeline Insights

This “ Retinitis Pigmentosa (Retinitis)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the...

February 2015
FROM

Rhino-Conjunctivitis-Pipeline Insights

This “ Rhino-Conjunctivitis-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Complicated Skin And Skin Structure Infections (cSSSI)-Pipeline Insights

This “ Complicated Skin And Skin Structure Infections (cSSSI)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report...

February 2015
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S